This company is no longer active
La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Tricida Croissance future
Future contrôle des critères 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Tricida.
Informations clés
57.3%
Taux de croissance des bénéfices
58.1%
Taux de croissance du BPA
Pharmaceuticals croissance des bénéfices | 23.7% |
Taux de croissance des recettes | n/a |
Rendement futur des capitaux propres | n/a |
Couverture par les analystes | Low |
Dernière mise à jour | 29 Mar 2023 |
Mises à jour récentes de la croissance future
Recent updates
Tricida enters $125M debt facility
Oct 19Tricida: Important Binary Event Coming Up
Sep 21Calculating The Intrinsic Value Of Tricida, Inc. (NASDAQ:TCDA)
Sep 14Insider Buying: The Tricida, Inc. (NASDAQ:TCDA) CFO & Executive VP Just Bought 6.5% More Shares
Dec 14Tricida revises VALOR-CKD trial protocol, updates patent protection, shares down 14%
Dec 09Tricida's Veverimer CRL And Regulatory Updates: An Analysis
Nov 17Tricida slumps 46% on FDA feedback on veverimer proposal; launches cost-cutting initiatives
Oct 29Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
12/31/2023 | N/A | -58 | -29 | -29 | 1 |
12/31/2022 | N/A | -109 | -89 | -89 | 1 |
9/30/2022 | N/A | -134 | -109 | -109 | N/A |
6/30/2022 | N/A | -148 | -119 | -119 | N/A |
3/31/2022 | N/A | -153 | -136 | -135 | N/A |
12/31/2021 | N/A | -177 | -140 | -140 | N/A |
9/30/2021 | N/A | -181 | -145 | -144 | N/A |
6/30/2021 | N/A | -219 | -177 | -176 | N/A |
3/31/2021 | N/A | -244 | -212 | -211 | N/A |
12/31/2020 | N/A | -265 | -233 | -231 | N/A |
9/30/2020 | N/A | -268 | -220 | -219 | N/A |
6/30/2020 | N/A | -235 | -202 | -201 | N/A |
3/31/2020 | N/A | -213 | -158 | -157 | N/A |
12/31/2019 | N/A | -177 | -131 | -130 | N/A |
9/30/2019 | N/A | -146 | -134 | -133 | N/A |
6/30/2019 | N/A | -131 | -119 | -118 | N/A |
3/31/2019 | N/A | -120 | -104 | -104 | N/A |
12/31/2018 | N/A | -103 | -96 | -95 | N/A |
9/30/2018 | N/A | -96 | -79 | -78 | N/A |
6/30/2018 | N/A | -77 | -60 | -58 | N/A |
3/31/2018 | N/A | -60 | -49 | -47 | N/A |
12/31/2017 | N/A | -41 | -41 | -40 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: TCDA.Q is forecast to remain unprofitable over the next 3 years.
Bénéfices vs marché: TCDA.Q is forecast to remain unprofitable over the next 3 years.
Croissance élevée des bénéfices: TCDA.Q is forecast to remain unprofitable over the next 3 years.
Chiffre d'affaires vs marché: Insufficient data to determine if TCDA.Q's revenue is forecast to grow faster than the US market.
Croissance élevée des revenus: TCDA.Q is forecast to have no revenue next year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Insufficient data to determine if TCDA.Q's Return on Equity is forecast to be high in 3 years time